Literature DB >> 18278577

Cholera toxin structure, gene regulation and pathophysiological and immunological aspects.

J Sánchez1, J Holmgren.   

Abstract

Many notions regarding the function, structure and regulation of cholera toxin expression have remained essentially unaltered in the last 15 years. At the same time, recent findings have generated additional perspectives. For example, the cholera toxin genes are now known to be carried by a non-lytic bacteriophage, a previously unsuspected condition. Understanding of how the expression of cholera toxin genes is controlled by the bacterium at the molecular level has advanced significantly and relationships with cell-density-associated (quorum-sensing) responses have recently been discovered. Regarding the cell intoxication process, the mode of entry and intracellular transport of cholera toxin are becoming clearer. In the immunological field, the strong oral immunogenicity of the non-toxic B subunit of cholera toxin (CTB) has been exploited in the development of a now widely licensed oral cholera vaccine. Additionally, CTB has been shown to induce tolerance against co-administered (linked) foreign antigens in some autoimmune and allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278577     DOI: 10.1007/s00018-008-7496-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  91 in total

1.  Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras.

Authors:  Juliette K Tinker; Chadwick T Davis; Britni M Arlian
Journal:  Protein Expr Purif       Date:  2010-05-11       Impact factor: 1.650

Review 2.  Unifying themes in microbial associations with animal and plant hosts described using the gene ontology.

Authors:  Trudy Torto-Alalibo; Candace W Collmer; Michelle Gwinn-Giglio; Magdalen Lindeberg; Shaowu Meng; Marcus C Chibucos; Tsai-Tien Tseng; Jane Lomax; Bryan Biehl; Amelia Ireland; David Bird; Ralph A Dean; Jeremy D Glasner; Nicole Perna; Joao C Setubal; Alan Collmer; Brett M Tyler
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

3.  Increased immunogenicity to LipL32 of Leptospira interrogans when expressed as a fusion protein with the cholera toxin B subunit.

Authors:  Alejandra Habarta; Patricia A E Abreu; Noelia Olivera; Pricila Hauk; Maia T Cédola; María F Ferrer; Paulo L Ho; Ricardo M Gomez
Journal:  Curr Microbiol       Date:  2010-08-19       Impact factor: 2.188

4.  Fucosylation and protein glycosylation create functional receptors for cholera toxin.

Authors:  Amberlyn M Wands; Akiko Fujita; Janet E McCombs; Jakob Cervin; Benjamin Dedic; Andrea C Rodriguez; Nicole Nischan; Michelle R Bond; Marcel Mettlen; David C Trudgian; Andrew Lemoff; Marianne Quiding-Järbrink; Bengt Gustavsson; Catharina Steentoft; Henrik Clausen; Hamid Mirzaei; Susann Teneberg; Ulf Yrlid; Jennifer J Kohler
Journal:  Elife       Date:  2015-10-29       Impact factor: 8.140

5.  Cholera toxin enhances Na(+) absorption across MCF10A human mammary epithelia.

Authors:  Qian Wang; Bruce D Schultz
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-26       Impact factor: 4.249

6.  Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine.

Authors:  Zoe Hunter; Hugh D Smyth; Paul Durfee; Bryce Chackerian
Journal:  Vaccine       Date:  2009-10-20       Impact factor: 3.641

Review 7.  Structure, biological functions and applications of the AB5 toxins.

Authors:  Travis Beddoe; Adrienne W Paton; Jérôme Le Nours; Jamie Rossjohn; James C Paton
Journal:  Trends Biochem Sci       Date:  2010-03-02       Impact factor: 13.807

8.  Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers.

Authors:  Neha Kohli; Donevan R Westerveld; Alexandra C Ayache; Amrisha Verma; Pollob Shil; Tuhina Prasad; Ping Zhu; Sic L Chan; Qiuhong Li; Henry Daniell
Journal:  Mol Ther       Date:  2013-12-06       Impact factor: 11.454

9.  Oral immunisation of mice with transgenic rice calli expressing cholera toxin B subunit fused to consensus dengue cEDIII antigen induces antibodies to all four dengue serotypes.

Authors:  Mi-Young Kim; Byeong-Young Kim; Sun-Mi Oh; Rajko Reljic; Yong-Suk Jang; Moon-Sik Yang
Journal:  Plant Mol Biol       Date:  2016-08-26       Impact factor: 4.076

10.  Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin.

Authors:  David J M Lewis; Zhiming Huo; Susan Barnett; Ingrid Kromann; Rafaela Giemza; Eva Galiza; Maria Woodrow; Birgit Thierry-Carstensen; Peter Andersen; Deborah Novicki; Giuseppe Del Giudice; Rino Rappuoli
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.